Schonfeld Strategic Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-31,900
| Closed | -$61K | – | 2462 |
|
2022
Q3 | $61K | Buy |
+31,900
| New | +$61K | ﹤0.01% | 2555 |
|
2022
Q1 | – | Sell |
-12,500
| Closed | -$49K | – | 2347 |
|
2021
Q4 | $49K | Sell |
12,500
-133,300
| -91% | -$523K | ﹤0.01% | 1878 |
|
2021
Q3 | $626K | Buy |
+145,800
| New | +$626K | 0.01% | 1092 |
|
2021
Q2 | – | Sell |
-12,719
| Closed | -$42K | – | 1851 |
|
2021
Q1 | $42K | Buy |
+12,719
| New | +$42K | ﹤0.01% | 1682 |
|
2017
Q4 | – | Sell |
-125,000
| Closed | -$775K | – | 708 |
|
2017
Q3 | $775K | Buy |
+125,000
| New | +$775K | 0.07% | 310 |
|